Skip to main content
. 2019 Sep 18;5(1):e10142. doi: 10.1002/btm2.10142

Figure 5.

Figure 5

Vaccination of transgenic mice that spontaneously develop breast cancer with a phage‐displayed HER2 variant (a) thought to be associated with oncogenesis results in decreased tumor frequency (b) and volume (c). Reprinted by permission from the American Association for Cancer Research: Bartolacci C, Andreani C, Curcio C, et al., Phage‐based anti‐HER2 vaccination can circumvent immune tolerance against breast cancer. Cancer Immunol Res. December 2018;6(12):1486–1498. doi:10.1158/2326‐6,066.CIR‐18‐017997